Medicare Rx "On Track And On Schedule," CMS' McClellan Says; "Non-Interference" Not An Issue
This article was originally published in The Pink Sheet Daily
Executive Summary
The Senate's rejection of legislation to allow HHS intervention in Medicare drug price negotiations reflects the Centers for Medicare & Medicaid Services' confidence that the new outpatient drug benefit will be working as planned on Jan. 1, CMS Administrator Mark McClellan said March 17